HomeCompareBDGS vs JNJ

BDGS vs JNJ: Dividend Comparison 2026

BDGS yields 0.57% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BDGS wins by $453.00 in total portfolio value
10 years
BDGS
BDGS
● Live price
0.57%
Share price
$33.54
Annual div
$0.19
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.5K
Annual income
$59.28
Full BDGS calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BDGS vs JNJ

📍 BDGS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBDGSJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BDGS + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BDGS pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BDGS
Annual income on $10K today (after 15% tax)
$48.55/yr
After 10yr DRIP, annual income (after tax)
$50.39/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $653.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BDGS + JNJ for your $10,000?

BDGS: 50%JNJ: 50%
100% JNJ50/50100% BDGS
Portfolio after 10yr
$20.2K
Annual income
$443.53/yr
Blended yield
2.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BDGS
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BDGS buys
0
JNJ buys
0
No recent congressional trades found for BDGS or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBDGSJNJ
Forward yield0.57%3.36%
Annual dividend / share$0.19$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.5K$20.0K
Annual income after 10y$59.28$827.78
Total dividends collected$583.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BDGS vs JNJ ($10,000, DRIP)

YearBDGS PortfolioBDGS Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,757$57.12$10,676$355.77+$81.00BDGS
2$11,568$57.42$11,407$389.39+$161.00BDGS
3$12,435$57.71$12,198$426.53+$237.00BDGS
4$13,363$57.98$13,056$467.62+$307.00BDGS
5$14,357$58.23$13,987$513.12+$370.00BDGS
6$15,421$58.47$14,998$563.56+$423.00BDGS
7$16,559$58.69$16,098$619.52+$461.00BDGS
8$17,777$58.90$17,295$681.69+$482.00BDGS
9$19,080$59.09$18,599$750.82+$481.00BDGS
10$20,475$59.28$20,022$827.78+$453.00BDGS

BDGS vs JNJ: Complete Analysis 2026

BDGSStock

The fund is an actively managed, diversified exchange-traded fund (“ETF”) that seeks to achieve its investment objective by investing in a blend of passively managed U.S. equity index ETFs, large-capitalization equity securities and cash or cash equivalents. It is expected that the fund will generally hold 5 to 20 investments selected from a universe that includes large-capitalization U.S. equity securities and passively managed index ETFs tracking U.S. small-, mid- and large-capitalization equity indexes (the “Indexes”).

Full BDGS Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BDGS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BDGS vs SCHDBDGS vs JEPIBDGS vs OBDGS vs KOBDGS vs MAINBDGS vs ABBVBDGS vs MRKBDGS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.